This product is a recombinant antibody that recognizes IL13. The monoclonal antibody V2.11 reacts with the epitope of IL13. The inhibitory activity of V2.11 was comparable to that of sIL-13Ra2-Fc.
Figure 1 A graph depicts the neutralization of NHP IL-13 activity by humanized MJ2-7 v.211.
Figure 2 A graph depicts the neutralization of NHP IL-13 activity by humanized MJ2-7 v.211.
Figure 3 A graph depicts the binding of varying concentrations (0.09-600 nM) of NHP IL-13 to captured hMJ2-7 v.2-11 antibody.
Figure 4 Show total of BAL cells/ml in BAL fluids in control and antibody-treated cynomolgus monkeys pre- and post-Ascaris challenge.
Figure 5 Depicts a decrease in eotaxin levels in concentrated BAL fluids from cynomolgus monkeys treated with mAb 13.2-(gray circles) or MJ2-7-(gray triangles) antibodies compared to a control (dark circles).
Figure 6 Shows the concentrations of [125I]-labeled humanized 13.2v.2 anti-IL-13 antibody and [251I]-labeled humanized MJ2-7v.2-11 antibody in various mouse and rat tissue, respectively.
Figure 7 Showing observed and predicted IL-13 and anti-IL-13 antibody levels over time.
1 mg/kg of humanized MJ2-7v.2-11 antibody was administered to naïve cynomolgus monkeys. Total IL-13 and humanized MJ2-7v.2-11 serum levels were quantified over a period of 0-45 days using a specific ELISA.
Figure 8 Showing observed and predicted IL-13 and anti-IL-13 antibody levels over time.
1 mg/kg of humanized MJ2-7v.2-11 antibody was administered to naïve cynomolgus monkeys. Total IL-13 and humanized MJ2-7v.2-11 serum levels were quantified over a period of 0-45 days using a specific ELISA.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-395CL | Human Anti-IL13 Recombinant Antibody (TAB-395CL) | FuncS | Human IgG |
TAB-043ZJ-S(P) | Anti-Human IL-13 Recombinant Antibody scFv Fragment (Lc6Hc2) | ELISA | Humanized antibody |
TAB-044ZJ-S(P) | Human Anti-IL13 Recombinant Antibody; scFv Fragment (TAB-044ZJ-S(P)) | ELISA, Neut | Humanized scFv |
TAB-045ZJ-S(P) | Human Anti-IL13 Recombinant Antibody; scFv Fragment (TAB-045ZJ-S(P)) | ELISA, Block | Humanized scFv |
TAB-046ZJ-S(P) | Human Anti-IL13 Recombinant Antibody; scFv Fragment (TAB-046ZJ-S(P)) | ELISA, Block | Humanized scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
PFBL-232 | Human Anti-IL13 Recombinant Antibody (clone M1295); Fab Fragment | WB, IHC, FuncS | Human Fab |
PFBL-598 | Human Anti-IL13 Recombinant Antibody (clone C836); Fab Fragment | Neut | Chimeric (mouse/human) Fab |
PFBL-600 | Human Anti-IL13 Recombinant Antibody (clone H2L6); Fab Fragment | ELISA | Humanized Fab |
PFBL-601 | Human Anti-IL13 Recombinant Antibody (clone X836); Fab Fragment | WB, ELISA, FuncS | Chimeric (mouse/human) Fab |
HPAB-0045LY-F(E) | Human Anti-IL13 Recombinant Antibody (clone IMA-026); Fab Fragment | WB | Humanized Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
PABL-603 | Human Anti-IL13 Recombinant Antibody (clone C836) | Neut | Chimeric (mouse/human) IgG |
PABL-605 | Human Anti-IL13 Recombinant Antibody (clone H2L6) | ELISA | Humanized IgG |
PABL-606 | Human Anti-IL13 Recombinant Antibody (clone X836) | WB, ELISA, FuncS | Chimeric (mouse/human) IgG |
HPAB-0226CQ | Human Anti-IL13 Recombinant Antibody (HPAB-0226CQ) | ELISA, Neut, FC, FuncS | Human IgG2 |
HPAB-0227CQ | Human Anti-IL13 Recombinant Antibody (HPAB-0227CQ) | ELISA, Neut, FC, FuncS | Human IgG2 |
CAT | Product Name | Application | Type |
---|---|---|---|
PSBL-598 | Mouse Anti-IL13 Recombinant Antibody (clone C836); scFv Fragment | Neut | Mouse scFv |
HPAB-0033-WJ-S(P) | Mouse Anti-IL13 Recombinant Antibody; scFv Fragment (HPAB-0033-WJ-S(P)) | ELISA, WB | Mouse scFv |
HPAB-0286-YJ-S(P) | Human Anti-IL13 Recombinant Antibody; scFv Fragment (HPAB-0286-YJ-S(P)) | ELISA, Antagonist, FuncS | Human scFv |
HPAB-0287-YJ-S(P) | Mouse Anti-IL13 Recombinant Antibody; scFv Fragment (HPAB-0287-YJ-S(P)) | ELISA, Neut, Inhib, FuncS | Mouse scFv |
HPAB-0288-YJ-S(P) | Mouse Anti-IL13 Recombinant Antibody; scFv Fragment (HPAB-0288-YJ-S(P)) | ELISA, Neut, Inhib, FuncS | Mouse scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-022ZJ | Anti-Human IL-13 Recombinant Antibody (C836) | ELISA | |
TAB-023ZJ | Mouse Anti-IL13 Recombinant Antibody (TAB-023ZJ) | ELISA, Block | Mouse IgG |
TAB-022ZJ-S(P) | Anti-Human IL-13 Recombinant Antibody scFv Fragment (C836) | ELISA | |
TAB-022ZJ-F(E) | Anti-Human IL-13 Recombinant Antibody Fab Fragment (C836) | ELISA | |
TAB-023ZJ-F(E) | Mouse Anti-IL13 Recombinant Antibody; Fab Fragment (TAB-023ZJ-F(E)) | ELISA, Block | Mouse Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-094ZJ | Anti-Human IL-13 Recombinant Antibody (167) | ELISA | Chimeric antibody (mouse/human) |
TAB-094ZJ-S(P) | Anti-Human IL-13 Recombinant Antibody scFv Fragment (167) | ELISA | Chimeric antibody (mouse/human) |
TAB-094ZJ-F(E) | Anti-Human IL-13 Recombinant Antibody Fab Fragment (167) | ELISA | Chimeric antibody (mouse/human) |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-067ZJ-S(P) | Anti-Human IL-13 Recombinant Antibody scFv Fragment (CNTO 607) | ELISA, Inhib | Human antibody |
TAB-068ZJ-S(P) | Anti-Human IL-13 Recombinant Antibody scFv Fragment (01471/G6) | ELISA, Neut | Human antibody |
TAB-069ZJ-S(P) | Human Anti-IL13 Recombinant Antibody; scFv Fragment (TAB-069ZJ-S(P)) | ELISA, Neut, FC | Human scFv |
TAB-070ZJ-S(P) | Human Anti-IL13 Recombinant Antibody; scFv Fragment (TAB-070ZJ-S(P)) | ELISA, Neut, FC | Human scFv |
TAB-017ML | Anti-Human IL13 Recombinant Antibody (Dectrekumab) | ELISA, IHC, FC, IP, IF, Inhib | IgG1, κ |
CAT | Product Name | Application | Type |
---|---|---|---|
NEUT-1171CQ | Mouse Anti-IL13 Recombinant Antibody (clone B-B13) | ELISA, ELISPOT, Neut | Mouse IgG1 |
NEUT-1172CQ | Mouse Anti-IL13 Recombinant Antibody (clone 10X28) | Neut, WB | Mouse IgG1 |
NEUT-1173CQ | Mouse Anti-IL13 Recombinant Antibody (clone 15H10) | Neut | Mouse IgG2b |
NEUT-1174CQ | Mouse Anti-IL13 Recombinant Antibody (clone 32116.11) | ELISA, Neut, WB | Mouse IgG1 |
NEUT-1175CQ | Rat Anti-IL13 Recombinant Antibody (clone 5A2) | Neut | Rat IgG1 |
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-1790 | Rabbit Anti-IL13 Recombinant Antibody (clone DS1790AB) | WB, ICC, FC, IP | Rabbit IgG |
MOR-4610 | Rabbit Anti-IL13 Recombinant Antibody (clone TH123DS) | WB | Rabbit IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
AFC-TAB-H05 | Afuco™ Anti-IL13 ADCC Recombinant Antibody (Anrukinzumab), ADCC Enhanced | FC, IP, ELISA, Neut, FuncS, IF | ADCC enhanced antibody |
AFC-TAB-017ML | Afuco™ Anti-IL13 ADCC Recombinant Antibody (Dectrekumab), ADCC Enhanced | ELISA, IHC, FC, IP, IF, Inhib | ADCC enhanced antibody |
AFC-TAB-219 | Afuco™ Anti-IL13 ADCC Recombinant Antibody (Lebrikizumab), ADCC Enhanced | ELISA, Neut, IF, IP, FC, FuncS | ADCC enhanced antibody |
AFC-TAB-218 | Afuco™ Anti-IL13 ADCC Recombinant Antibody (Tralokinumab), ADCC Enhanced | ELISA, FC, IP, FuncS, IF, Neut | ADCC enhanced antibody |
There are currently no Customer reviews or questions for HPAB-1742-FY. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.